Foamix Announces Positive Results From Phase 1 Study to Characterize Minocycline Bioavailability of FMX-101 Compared to Solodyn® (Minocycline HCl) Extended-Release Tablets
07 janv. 2016 16h01 HE
|
Foamix, Ltd.
Minocycline Systemic Bioavailability For FMX-101 Was More Than 100 Times Lower Than That For Solodyn. FMX-101 Was Well-Tolerated. REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 07, 2016 (GLOBE...